KFDA drafted revised new drug registration provision.

The KFDA plans to held a public hearing at the auditorium hall of the KPA on April 27 over the revised draft of new drug registration system replacing the current domestic clinical phase III study obligated to a new drug of foreign origin with so called a bridging study. The followings are summary of the draft.

Key issues of public hearing.

-Draft of bridging study to be newly adopted.
-...